Incidence and management of diarrhoea associated with abemaciclib and endocrine therapy for hormone-receptor positive, HER2-negative metastatic breast cancer: the UK patients’ experiences
Helena Harder(University of Sussex), Valerie Shilling(Brighton and Sussex Medical School)
Cited by 2